Ad is loading...
JANBX
Price
$48.15
Change
-$0.51 (-1.05%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

JANBX vs RLEFX

Header iconJANBX vs RLEFX Comparison
Open Charts JANBX vs RLEFXBanner chart's image
Janus Henderson Balanced D
Price$48.15
Change-$0.51 (-1.05%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
JANBX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JANBX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JANBX is a StrongBuy and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. JANBX (26B). RLEFX pays higher dividends than JANBX: RLEFX (2.42) vs JANBX (1.91). JANBX was incepted earlier than RLEFX: JANBX (32 years) vs RLEFX (9 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. JANBX (92.00). RLEFX has a lower initial minimum investment than JANBX: RLEFX (250) vs JANBX (2500). RLEFX (21.09) and JANBX (21.04) have marching annual gain over last year. JANBX return over 5 years is better than : 42.49 vs. RLEFX (35.95).
JANBXRLEFXJANBX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years9 years-
Gain YTD15.31614.211108%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets26B236B11%
Annual Yield % from dividends1.912.4279%
Returns for 1 year21.0421.09100%
Returns for 3 years7.2110.9566%
Returns for 5 years42.4935.95118%
Returns for 10 years79.06N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology